Transplantation and cellular therapy | Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF

Risk Factors for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia.

Transplantation and cellular therapy

Kevin Owen McNerney, Vanessa A. Fabrizio, Aimee C. Talleur, Stephanie Si Lim, Alexandra Dreyzin, Christina Baggott, Anant Vatsayan, Snehit Prabhu, Jenna Rossoff, Holly L Pacenta, Christine L Phillips, Julie A Talano, Amy Moskop, Michael R. Verneris, Doug Myers, Nicole Karras, Challice L Bonifant, Muna Qayed, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H.C. Baumeister, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Kevin J. Curran, Crystal L. Mackall, Theodore W Laetsch, Liora Michal Schultz, Swati Naik

Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols.

Transplantation and cellular therapy

Salinas Cisneros G, Dvorak CC, Long-Boyle J, Kharbanda S, Shimano KA, Melton A, Chu J, Winestone LE, Dara J, Huang JN, Hermiston ML, Zinter M, Higham CS

Cyclophosphamide and thiotepa increases risk of transplant-associated thrombotic microangiopathy.

Transplantation and cellular therapy

Higham CS, Shimano KA, Kharbanda S, Chu J, Cisneros GS, Winestone LE, Dara J, Huang JN, Hermiston ML, Long-Boyle JR, Dvorak CC

A Cure for Sickle Cell Disease.

Transplantation and cellular therapy

Walters M

Epidemiology of Diffuse Alveolar Hemorrhage in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients.

Transplantation and cellular therapy

Cheng G, Smith MA, Phelan R, Brazauskas R, Strom J, Ahn KW, Hamilton B, Peterson A, Savani B, Schoemans H, Schoettler M, Sorror M, Higham C, Kharbanda S, Dvorak CC, Zinter MS

A Phase 1 Trial of Targeted Immunotherapy with Daratumumab Following Myeloablative Total Body Irradiation (TBI)-Based Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) in Children, Adolescents and Young Adults with High-Risk T-Cell Acut

Transplantation and cellular therapy

Allyson Flower, Troy C. Quigg, David T. Teachey, Megan Lim, Yanling Liao, Lauren Harrison, Erin Morris, Amir Steinberg, Stephan Voss, Rodney R Miles, Xiaokui Mo, Joseph Stanek, Adam Olshen, Michelle Hermiston, Alix E. Seif, Mitchell S. Cairo

Fludarabine Pharmacokinetic-Model-Based Dosing Minimizes the Risk of Graft Rejection in Pediatric Patients Undergoing Mismatched Allogeneic Hematopoietic Cell Transplantation.

Transplantation and cellular therapy

Christopher C. Dvorak, William C. Temple, Gabriel Salinas Cisneros, Julia Chu, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, Sandhya Kharbanda, Serine Avagyan, Michelle Hermiston, James N. Huang, Janel Renee Long-Boyle

High Exposure of Intravenous Alemtuzumab Is Associated with Increased Risk of Double-Stranded DNA Viral Infections in Patients with Non-Malignant Disease Undergoing Allogeneic HCT.

Transplantation and cellular therapy

Gabriel Salinas Cisneros, Janel Renee Long-Boyle, William C. Temple, Julia Chu, Serine Avagyan, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, James N. Huang, Michelle Hermiston, Sandhya Kharbanda, Christopher C. Dvorak

Liberalizing Requirements for Hospital Proximity Post-CD19 CAR for Children with Low Burden B-ALL at Infusion.

Transplantation and cellular therapy

Lauren Appell, Arunkumar Modi, Christina Baggott, Khanh Nguyen, Snehit Prabhu, Holly L Pacenta, Vanessa A. Fabrizio, Christine L. Phillips, Jenna Rossoff, Heather Emily Stefanski, Julie A Talano, Amy Moskop, Rachel Phelan, Susanne Baumeister, Michael R. Verneris, Erin M. Hall, Gary Myers, Nicole Karras, Stacy Cooper, Muna Qayed, Sunil S. Raikar, Lena E. Winestone, Michelle Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Danielle Friedman, Kevin J. Curran, Crystal L. Mackall, Samuel John, Theodore W Laetsch, Kevin Owen McNerney, Liora Schultz

Younger Children Have Increased Mixed Myeloid Chimerism with Busulfan-Based Conditioning for Hematopoietic Cell Transplantation of Non-Malignant Disease.

Transplantation and cellular therapy

Subscribe to Transplantation and cellular therapy